The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 719-723 , October 2008

Increased risk of serious pneumococcal disease in patients with asthma

  • Young J. Juhn, MD, MPH

      Affiliations

    • Departments of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn
    • Corresponding Author InformationReprint requests: Young J. Juhn, MD, MPH, Division of Community Pediatric and Adolescent Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN 55905.
    • ,
  • Hirohito Kita, MD

      Affiliations

    • Departments of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn
    • ,
  • Barbara P. Yawn, MD, MSc

      Affiliations

    • Department of Research, Olmsted Medical Center, Rochester, Minn
    • ,
  • Thomas G. Boyce, MD, MPH

      Affiliations

    • Departments of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn
    • ,
  • Kwang H. Yoo, MD, PhD

      Affiliations

    • Departments of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn
    • Department of Internal Medicine, Kunkook University School of Medicine, Seoul, South Korea
    • ,
  • Michaela E. McGree, BS

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic, Rochester, Minn
    • ,
  • Amy L. Weaver, MS

      Affiliations

    • Department of Health Sciences Research, Mayo Clinic, Rochester, Minn
    • ,
  • Peter Wollan, PhD

      Affiliations

    • Department of Research, Olmsted Medical Center, Rochester, Minn
    • ,
  • Robert M. Jacobson, MD

      Affiliations

    • Departments of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn

Received 27 October 2007 ,Revised 3 July 2008 ,Accepted 28 July 2008.

References 

  1. Lethbridge-Cejku M, Pleis JR. Summary of health statistics for US adults: National Health Interview Survey, 2005. Vital & Health Statistics-Series 10: Data from the Health Survey. Hyattsville (MD): National Center for Health Statistics; 2006;p. 1-153
  2. Anonymous. Forecasted state-specific estimates of self-reported asthma prevalence—United States, 1998. MMWR Morb Mortal Wkly Rep. 1998;47:1022–1025
  3. World Health Organization. Fact sheet for asthma. August, 2005; Fact Sheet for Asthma N307. Available at: http://www.who.int/int/mediacentre/factsheets/fs307/en/. Accessed October 26, 2006.
  4. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733–743
  5. Chinn S, Jarvis D, Burney P, Luczynska C, Ackermann-Liebrich U, Antó JM, et al. Increase in diagnosed asthma but not in symptoms in the European Community Respiratory Health Survey. Thorax. 2004;59:646–651
  6. Yunginger J, Reed CE, O'Connell EJ, Melton J, O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma: incidence rates, 1964-1983. Am Rev Respir Dis. 1992;146:888–894
  7. Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA. 2001;285:1729–1735
  8. Talbot T, Hartert TV, Arbogast PG, Mitchel E, Schaffner K, Craig AS, et al. Asthma as a Risk Factor for Invasive Pneumococcal Disease. N Engl J Med. 2005;352:2082–2090
  9. Yunginger JW, Reed CE, O'Connell EJ, Melton LJ, O'Fallon WM, Silverstein MD. A community-based study of the epidemiology of asthma: incidence rates, 1964-1983. Am Rev Respir Dis. 1992;146:888–894
  10. Katusic SK, Colligan RC, Barbaresi WJ, Schaid DJ, Jacobsen SJ. Potential influence of migration bias in birth cohort studies. Mayo Clin Proc. 1998;73:1053–1061
  11. US Census Bureau. 1980 and 1990 Census of Population and Housing. In: Bureau UC, editor. Washington (DC): US Department of Commerce; 1980 and 1990. PHC80-2-305.
  12. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245:54–63
  13. Broder I, Higgins MW, Mathews KP, Keller JB. Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan. IV. Natural history. J Allergy Clin Immunol. 1974;54:100–110
  14. Beard M, Yunginger JW, Reed CE, O'Connell EJ, Silverstein MD. Interobserver variability in medical record review: an epidemiological study of asthma. J Clin Epidemiol. 1992;45:1013–1020
  15. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340–349
  16. Kelsey J, Whittemore A, Evans A, Thompson W. Methods in observational epidemiology. Oxford: Oxford University Press; 1996;
  17. American Academy of Pediatrics . Red Book 2006. Elk Grove Village (IL): American Academy of Pediatrics; 2006;
  18. Juhn YJ, Kita H, Lee LA, Swanson RJ, Smith R, Bagniewski SM, et al. Childhood Asthma and Measles Vaccine Response. Ann Allergy Asthma Immunol. 2006;97:469–476
  19. CDC . Active bacterial core surveillance report: emerging infectious program network Streptococcus pneumoniae. Atlanta: CDC; 1997-1999;
  20. Grove DI BT, Wellby ML, Ford RM, Forbes IJ. Humoral and cellular immunity in asthma. J Allergy Clin Immunol. 1975;55:152–163
  21. Arkwright P, Moran P, Haeney M, Ewing C, David T. Atopic eczema is associated with delayed maturation of the antibody response to pneumococcal vaccine. Clin Exp Immunol. 2000;122:16–19
  22. Lee HJ, Kang JH, Henrichsen J, Konradsen HB, Jang SH, Shin HY, et al. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine. 1995;13:1533–1538
  23. Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342:681–689
  24. Tsigrelis C, Tleyjeh I, Lahr B, Virk A, Baddour L. Temporal trends in invasive pneumococcal disease—a population-based study in Olmsted County, Minnesota, 1999-2006. Paper presented at: 45th Annual Infectious Disease Society of America (ISDA); October 4-7, 2007; San Diego, Calif.
  25. Busse WW. Pathogenesis and sequelae of respiratory infections. Rev Infect Dis. 1991;13(suppl 6):S477–S485
  26. Fahy JV, Corry DB, Boushey HA. Airway inflammation and remodeling in asthma. Curr Opin Pulm Med. 2000;6:15–20
  27. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201:937–947
  28. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12:1023–1026
  29. Lahood N, Emerson SS, Kumar P, Sorensen RU. Antibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Ann Allergy. 1993;70:289–294
  30. Fischer JE, Johnson JE, Kuli-Zade RK, Johnson TR, Aung S, Parker RA, et al. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol. 1997;71:8672–8677
  31. Kincy-Cain T, Clements JD, Bost KL. Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun. 1997;64:1437–1440
  32. Chaplin D, Zindl C, Duffy L, Atkinson T, Lai J. Clearance of Mycoplasma Pneumoniae is impaired in mice with established allergic airway inflammation. J Allergy Clin Immunol. 2007;119(suppl):S132

 Supported by a National Institutes of Health grant (R01 AI 56133) from the National Institute of Allergy and Infectious Diseases.

 Disclosure of potential conflict of interest: B. P. Yawn is on the advisory board for Schering-Plough; is on the speakers' bureau for AstraZeneca; has received research support from Schering-Plough, AstraZeneca, and Pfizer; and has served as a member of the Minnesota Asthma Coalition and EPR-3 National Heart, Lung, and Blood Institute. P. Wollan has received research support from AstraZeneca and the Agency for Healthcare Research and Quality. R. M. Jacobson has received research support from PSC Corp. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01362-6

doi: 10.1016/j.jaci.2008.07.029

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 719-723 , October 2008

Article Tools